Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Implementing Models for Continuous Treatment During the Pandemic And Beyond, Upcoming Webinar Hosted by Xtalks


With this change, it’s now more important than ever to ensure the right Investigational Medicinal Product (IMP) reaches the right patient at the right time.

The current pandemic has had a significant impact on clinical development, calling for the implementation of decentralized trials. With this change, it’s now more important than ever to ensure the right Investigational Medicinal Product (IMP) reaches the right patient at the right time.

So how do sponsors go about implementing direct-to-patient models and how do they maintain the chain of custody for the life of an IMP? This insightful webinar will take participants through the what, why and how of performing various direct-to-patient models. Participants will gain knowledge of the important areas to consider before executing, such as:


  • Additional data requirements needed
  • What information needs to be held in the Interactive Response Technology (IRT)
  • What steps can be taken to safeguard trials beyond the pandemic

Join expert speakers from Almac Clinical Technologies, Matt Lowrie, ASQ CQA, QA Manager, Quality Assurance; Abby Sener, Manager, Almac ONE, ACS Project Services; and Kat Williams, Manager, Clinical Project Services, in a live webinar on Tuesday, December 15, 2020 at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Direct-to-Patient: Implementing Models for Continuous Treatment During the Pandemic And Beyond.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Imaging AI and Machine Learning — Beyond the Hype, Upcoming Webinar Hosted by Xtalks


Learn what is available today in the current landscape, its applications for building efficiency and what is coming in the near future to help life science companies transform their clinical trial imaging.

For the first 125 years of medical imaging, technological advances focused primarily on new modes of imaging as technology progressed from the discovery of the X-ray in 1895 to ultrasounds, MRIs, PET and CT scans in the late 20th century. Now, arguably, the most notable advances are being made in how images from those technologies are securely shared, managed, stored and assessed. These advancements are largely due to the application of artificial intelligence (AI) and machine learning (ML) to imaging systems and data platforms.

Automation is improving virtually every stage of the imaging workflow, but there is a lot of hype concerning AI and ML in the marketplace. Companies have underestimated the challenge that complexity presents, and predictions of the end of radiologists have proven false multiple times.

Join experts from ICON Medical Imaging and Medidata for this webinar on the practical applications for AI and ML in clinical trial imaging and what is possible today. Learn what is available today in the current landscape, its applications for building efficiency and what is coming in the near future to help life science companies transform their clinical trial imaging.

Join Paul McCracken, Vice President, Head of Medical Imaging, ICON Medical Imaging; and Dan Braga, VP, Product Management, Acorn AI Product & Ecosystem, Medidata, in a live webinar on Wednesday, December 16, 2020 at 11am EST (8am PST).

For more information, or to register for this event, visit Imaging AI and Machine Learning — Beyond the Hype.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Early Global Impact and Ensuring Success with Pediatric Champions, Upcoming Webinar Hosted by Xtalks


What can we learn about the global impact of the RACE for Children Act in the first few months since its implementation? What is needed to ensure its ongoing success?

After three years of hard work by multiple diverse stakeholders, and with much anticipation, the RACE for Children Act became effective August 18th, 2020. This landmark legislation aims to dramatically shift the global landscape of clinical research in pediatric oncology and intends to bring new molecularly targeted cancer therapeutics to children, who have not been as greatly impacted by precision medicine over the past few decades compared to adults.

Whether the RACE for Children Act leads to the development of more drugs for children with cancer in the USA, and globally, remains to be seen. What can we learn about the global impact of the RACE for Children Act in the first few months since its implementation? What is needed to ensure its ongoing success?

Regulators, researchers, industry and patient advocates have come together to focus on not only curing childhood cancer but reducing long term side effects. Please join us in hearing from them in this webinar on what the early global impact of the RACE for Children Act looks like, and what is needed to ensure its success, including the critical function of pediatric champions.

Join Dr. Gregory Reaman, Associate Director for Pediatric Oncology, Oncology Center of Excellence, Center for Drug Evaluation and Research, US Food and Drug Administration; Prof. Gilles Vassal, Head of Pediatric Research Program, Gustave Roussy/Université Paris-Saclay and President ITCC, Chair of ACCELERATE; Dr. Anjali Sharma, Pediatric Oncology Development Lead and Early Oncology Development Lead, Amgen; and Dr. Beth Anne Baber, Founder & President, TigoHealth, in a live webinar on Thursday, December 17, 2020 at 10am EST (3pm GMT/UK).

For more information, or to register for this event, visit The RACE for Children Act: Early Global Impact and Ensuring Success with Pediatric Champions.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

MyoKardia and Medpace Talk Precision Medicine in Cardiovascular Disease, Upcoming Webinar Hosted by Xtalks


By matching mechanism of a drug action with specific disease etiology, precision-medicine approaches are starting to turn the page in CVD trials.

Despite advances in medical therapeutics, cardiovascular disease (CVD) remains the leading cause of death worldwide. Notably, heart failure and coronary disease continue to present an exorbitant burden on patients and health care. Recently, breakthroughs in precision medicine are creating optimism for a field that has historically witnessed few long-term successes in targeted therapeutic approaches.

Indeed, precision-medicine approaches target the subsets of patients that are most likely to benefit from a drug, including approaches based on mechanism of disease and shared patient characteristics. By matching mechanism of a drug action with specific disease etiology, precision-medicine approaches are starting to turn the page in CVD trials.

Investigational drugs like mavacamten, developed by MyoKardia, offer new hope for patients with hypertrophic cardiomyopathy (HCM), an inherited and often lethal primary myocardial disorder without effective pharmacological options. Indeed, the striking positive results found in obstructive and non-obstructive HCM patients are expected to support a New Drug Application (NDA) filing, thus commencing a new promising chapter in the precision-medicine approach to CVD drug discovery.

Join experts from Medpace and MyoKardia in a live webinar on Tuesday, December 15, 2020 at 12pm EST (5pm GMT/UK).

For more information, or to register for this event, visit From Promise to Reality: MyoKardia and Medpace Talk Precision Medicine in Cardiovascular Disease.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Trim Studio Launches Wellness Event Series in Clearwater, Hints at Expanding Treatment Modalities


A client undergoes non-invasive Verju Laser Treatment at Trim Studio in Clearwater, Florida.

A client undergoes non-invasive Verju Laser Treatment at Trim Studio in Clearwater, Florida.

“Though circumstances limited us a little bit in 2020, it also allowed us time to step back and reflect on how we might help our clients achieve more and better results.” -Corina Froese, Co-Founder at Trim Studio

Trim Studio is dedicated to helping clients achieve their goals through leading-edge technologies for fat reduction, cellulite treatment and skin toning without painful procedures, side effects or downtime. Their ongoing wellness event series will focus on therapies which support body contouring results and overall well being. For more information, visit their website.

“Throughout this year, we knew we’d need to get creative with how we make wellness resources available to our clients. The ‘quarantine 15’ joke is all too real for so many of us, and we feel lucky to work in a setting that allows for safe execution of events and one-on-one treatments at a safe social distance,” says Corina Froese, co-founder of Trim Studio.

Trim Studio was set to host their second annual Brunch and Yoga event in the spring of 2020 when pandemic-related circumstances made it impossible. After canceling, they shifted gears to smaller pop-up style events with a more intimate feel. Even with smaller events, Trim Studio intends to pack them with a punch of beneficial wellness and science-backed adjunct therapies.

In September, the Clearwater wellness boutique welcomed healthcare providers for vitamin injections and hormone wellness consultations. In November, an ozone sauna was made available to clients during a two day pop-up event which sold out in under 48 hours. In December, the Studio will be in Tampa for a one day event offering discounted body treatments and anti-aging CryoFacials at Femme Akoi Beauty Studio on Nebraska Avenue in Tampa.

“We absolutely love working with local wellness businesses that share our common goal to help clients improve their lifestyle and feel better. Though circumstances limited us a little bit in 2020, it also allowed us time to step back and reflect on how we might help our clients achieve more and better results—this is something that is always top of mind, and we definitely have some exciting news and changes to reveal in the new year!”

Trim Studio’s non-invasive Verju laser is FDA-cleared for reduction of cellulite, fat and overall body circumference. Verju is the world’s first green body contouring laser of its kind and the only body contouring device on the market with proven efficacy by way of a double-blind, multi-site and placebo-controlled clinical study in which clients saw a four-inch average loss after completion of a treatment program. The Studio also offers Cryoskin 3.0 technology which affords clients the opportunity to spot reduce stubborn body fat through cryolipolysis (fat freezing) as well as to reduce the appearance of cellulite and smooth facial wrinkles.

Trim Studio’s technologies are appropriate for body types ranging from athletic to clinically obese. For more information or to request a consultation contact them by calling 727-288-4329.

###

ABOUT TRIM STUDIO

Trim Studio is a wellness boutique located in Clearwater, Florida specializing in non-surgical body sculpting. Utilizing technologies such as Cryoskin 3.0 for cryolipolysis (fat freezing), skin toning, cellulite smoothing and facial rejuvenation as well as Verju (photoporosis) for fat and cellulite reduction, Trim Studio is dedicated to changing the body contouring game with effective tools for real, observable fat loss and improvements to skin’s elasticity and tone. For more information, please visit http://www.TrimStudioFL.com or visit the Studio on social media at @TrimStudioFL!

MEDIA CONTACT

Corina Froese

corina@dandelioncreativeco.com

727-441-1711

Share article on social media or email:

Chill-Pak Ramps Up Production to Aid In Distribution of Covid-19 Vaccines with Its Ultra-Cold Shippers


White Square Corrugated Outer Box Insulated with Polyurethane Foam Walls and Chill-Pak Logo

COVID-19 Ultra-Cold Vaccine Shipper

During these extraordinary times, state Departments of Health and logistics companies have been looking to us for assistance with specialty thermal coolers capable of meeting the rigorous temperature and duration specifications of Covid-19 vaccines.

Engineered Packaging, Inc. dba Chill-Pak™ a leading manufacturer and total solutions provider of sustainable cold-chain thermal packaging solutions for specialty pharmaceutical and life sciences applications announces the availability of its ISTA Qualified thermal insulated shippers designed for COVID-19 vaccines that need to be kept at ultra-low (-89ºC to -70ºC) temperatures over long durations (up to 120-hours).

“During these extraordinary times, state Departments of Health and logistics companies have been looking to us for assistance with specialty thermal coolers capable of meeting the rigorous temperature and duration specifications that Covid-19 vaccines require for storage and distribution to vaccine administration sites,” said Julie Kilgore, Vice President of Sales at Chill-Pak™. “We use proprietary recyclable polyurethane foam in multiple density formulations allowing us to provide solutions with performance-specific results. It is for this very reason we also have solutions for vaccines that require frozen (-20ºC), refrigerated (2-8ºC) and controlled room temperatures (15-30ºC) which span the entire temperature and duration spectrum.”

“From a manufacturing standpoint, three major cornerstones of our company identity are at play: our agility, just-in-time delivery, and mass production capabilities, all of which have allowed us to quickly ramp up to meet the unprecedented demand for vaccines shippers in a matter of days,” said Stephen Foster, President at Chill-Pak™. “With three decades of engineering and manufacturing experience, our team is prepared to deliver exceptional products to protect these lifesaving vaccines. We are honored to be playing a role as we all collectively battle against this disease.”

About Chill-Pak™

Engineered Packaging, Inc. dba Chill-Pak™ is a manufacturer and total solutions provider of sustainable cold-chain thermal packaging solutions for specialty pharmaceutical and Life Sciences applications. We create a positive impact for a better and healthier world through aggressive sustainability, diversity, and inclusion initiatives.

Share article on social media or email:

The onset of Covid-19 produced an unanticipated surge in Remote Care Technology product and service offerings according to leading health and senior care providers


The home will be come the hub for life and care.

The current status and future potential are discussed in the new report The Future of Remote Care Technology and Older Adults 2020 from Aging and Health Technology Watch. The report is based on interviews with experts from 30 organizations across healthcare and technology. Insights and report advice span telehealth, wearables, AI, smart home, and voice products and services.

Says Mary Furlong: “Laurie Orlov continues to deliver thought leadership and guidance that will help shape the longevity market in these difficult times.”

Tech industry veteran Laurie M. Orlov launched the market research company in 2009 with a blog, advisory services, and industry information which can be found at http://www.ageinplacetech.com.

Share article on social media or email:

BoniMedics partners with scar treatment pioneer, Biodermis® to bring Patented Pro-Sil® to Northern Europe


Bonimedics (a subsidiary company of StartUpPharma Int. AB) responded to a gap in the availability of quality, medical-grade silicone scar treatment options in the Nordic countries of Sweden, Denmark, Norway, and Finland by partnering with the US-based Biodermis. Established in 1988, Biodermis has been recognized for its innovative contributions to the scar management industry for over 30 years. BoniMedics is introducing Pro-Sil, in 4.25g and 17g sticks, as well as Pro-Sil with SPF-15 in both sizes. Additionally, Epi-Derm silicone sheeting and Epifoam compression foam will be offered.

Pro-Sil is revolutionary in its niche market of convenient, silicone-based scar care options because of its proprietary solid stick formulation. Biodermis recently emerged victorious following a legal challenge against a former Northern European distributor who violated the partnership by attempting to replicate patented silicone technology. In an effort to cut costs, the inferior silicone formula was diluted with excess SPF and other ingredients to a point below that which is proven to be effective with scar treatment. Pro-Sil’s patented, high silicone content stick formulation has proven itself in clinical trials as equally effective to gel products like Biodermis’ own Epi-Derm silicone sheeting. Pro-Sil is the only patented silicone therapy product available in a solid stick.

“This agreement with BoniMedics will ensure the availability of genuine Biodermis products in Northern Europe. BoniMedics has an outstanding track record in the pharmaceutical & medical device arena, but what’s more, is the foundation of our relationship with them. Biodermis has maintained a successful relationship with Bonimedics founders, Hamid Bakhshi and Sara Nikman, for over a decade. We are confident in their ability to promote our proven line of medical scar care solutions while upholding our high standard of customer service,” says Dr. Jeff Schleuning, Ph.D., Managing Partner, Biodermis.

Medical grade silicone effectively provides a fully-encapsulating healing environment for scar tissue and allows the ideal concentration of oxygen and moisture at the scar site. Silicone also provides smooth, even coverage across the scar and surrounding healthy tissue area. These factors help to keep the scar tissue pliable, allowing it to blend more completely with surrounding healthy tissue. The end result is a much-improved scar that has a smoother, flatter appearance, and a more natural skin tone.

With a focus on its ongoing and developing partnership with Biodermis, BoniMedics expects to expand on their scar management offerings and explore new markets under their umbrella organization StartUpPharma Int. AB, throughout 2020 and 2021.

BoniMedics, formed in 2020, is driven by over a decade of extensive experience in the medical device sales and distribution arena in the Nordics and Middle East. They are committed to providing quality and clinically proven products to help in the treatment and management of scars and related dermatology issues. BoniMedics can be reached online at BoniMedics.com or by phone at +46 (8) 604 48 88.

Share article on social media or email:

ABSTRAX Launches Premium Cannabis Derived High Terpene Extract (HTE) Catalog for California Vapes, Concentrates and Edibles


News Image

Abstrax HTE Fill

“Beyond offering the largest collection of premium botanically-derived terpenes, we also now offer our California partners the most expansive selection of the highest quality cannabis-derived terpenes and live resin extracts.”

ABSTRAX, an industry leader in the study and production of cannabis and botanically-derived terpenes, has launched the first standardized cannabis live resin High Terpene Extract (HTE) catalog for the California Cannabis, Vape, and Food/Beverage markets after unparalleled research and development efforts.

“This is a thrilling time for ABSTRAX and our customers,” says Max Koby, Founding Partner and Chief Executive Officer. “Beyond offering the largest collection of premium botanically-derived terpenes, we also now offer our California partners the most expansive selection of the highest quality cannabis-derived terpenes and live resin extracts. These are reshaping the way brands are developing their product offerings, by providing them the highest quality, active key flavor ingredients to create the optimal strain specific terpene profiles of the most desirable genetics in California.”

ABSTRAX offers a superior product to traditional flavor houses and extraction companies for the following reasons:

1. ABSTRAX product developers and scientists utilize proprietary, groundbreaking technologies to identify rare terpenes and aroma compounds that are hugely responsible for giving each strain its unique flavor and effects, whereas other organizations have access to outmoded technologies that don’t reveal the specifics of what makes leading strains so delicious and effective.

2. Other extraction companies lack the resources, technology, and testing capabilities to analyze hundreds of compounds to optimize their extraction processes and standardize product formulations.

3. Flavor companies do not have the proper licensing, facilities or technology for cannabis testing, research, extraction and formulation.

4. Other formulators are unable to develop cannabis products and test them to assure both quality and consistency of product formulations.

5. Flavor and aroma manufacturers do not produce products to the safety compliance specifications required by cannabis regulatory agencies including no residual solvents, heavy metals or pesticides.

6. There is limited access to study and extract the freshest samples of the most popular genetics in the world.

“Thanks to an amazing team of passionate researchers and the combination of our terpene manufacturing facility and state of the art licensed cannabis R&D Manufacturing lab (the only of its kind in the world), we’ve accomplished the feat of identifying more than 400 cannabis-derived terpenes (aroma and flavor compounds) in every sample we analyze. We use these research capabilities to optimize our cannabis terpene extracts, offer unparalleled terpene analysis, and also recreate any cannabis strain from botanically derived ingredients with an unwavering commitment to quality, consistency, and accuracy,” says Koby.

ABSTRAX uses 3D metabolite fingerprinting technology to discover and isolate hidden aroma and fragrance compounds that have been missed in previous efforts by other cannabis researchers and flavor houses. The company combines these advanced testing capabilities with its proprietary extraction process to yield the highest quality natural extracts, assuring they preserve and optimize the full spectrum of the terpene flavor profile.

With every product, ABSTRAX creates standardized product data sheets that map the entire profile of over 400 compounds to determine the specific flavor, aroma, strain balance, gas factor, fruit levels and other desirable qualities that help brands create memorable product experiences. Brands can use this technology and data to better educate consumers on the intended flavor and effects of these natural extracts.

“All of our live resin cannabis derived extracts are produced from the most premium strains and fresh frozen plants selected through our advanced research program, designed to discover and share the best cannabis terpene profiles in the world. We are the modern day Terp Hunters grown out of California, which has the most sought-after cannabis profiles and is the industry trendsetter for the entire world. Our research starts with the cannabis flower, but doesn’t end until we can offer the most premium terpene flavors from both cannabis and botanically-derived sources,” says Koby.

ABSTRAX also creates botanically derived versions of the best cannabis terpene profiles to help brands reproduce a targeted, repeatable and consistent product experience. The “secret sauce” lies in finding the perfect balance between the major and minor terpenes as well as the hidden aroma and flavor compounds. ABSTRAX does this by studying the cannabis flower and live resin extract to create identical botanically-derived terpenes and entourage-driven mental and physical effects.

“For years, we have specialized in cannabis research and extraction to create the most authentic, botanically derived cannabis profiles in the world. Now we are launching our cannabis derived terpene extracts and offering the next generation of Native Series™ botanical terpenes to recreate the same live resin experience for companies outside California that do not have access to our cannabis terpenes,” continued Koby.

For example, ABSTRAX has perfected a vape-ready Jack Herer blend that couldn’t be successfully recreated prior to its technological advancements with 3D metabolite fingerprinting. Other flavor houses had attempted to recreate the strain, but fell short because their analysis didn’t go deep enough.

“After partnering with Dan Herer to study and extract the original genetics, we discovered there are a few rare compounds (including ß-phellandrene in high concentration, which plays a crucial role in its unique flavor) that were not easily identified until our groundbreaking technologies made it possible,” says Koby.

ABSTRAX was able to bring together the exact aroma and flavor compounds (in their specific amounts) and recreate Jack Herer with unwavering precision and consistency. The company helped the Original Jack Herer Brand develop authenticated products including Live Resin Vapes in CA, Distillate Vape with the Native Series™ terpenes, terpene-infused rolling papers, and most recently a Jack Herer Beer. Now, the Original Jack Herer Brand has the ability to standardize their cannabis extracts, vape formulations, and CPG product applications across the country with other manufacturing partners.

By bringing together the key terpenes and compounds found in the Jack Herer strain, ABSTRAX’s blends also ensure consumers will enjoy similar physiological effects achieved when consuming infused products — such as increased energy and creativeness, followed by a relaxed “chilled” feeling as time progresses. This unique experience, known as the entourage effect, is produced by the terpenes and cannabinoids working together.

“It all comes down to our mastery of mapping cannabis terpene profiles from flower through extraction and developing quality centric testing standards to improve our quality metrics and help further educate consumers and empower the industry with scientifically driven data. Our analytical testing program focuses on: (1) The Gas Factor™ – the components giving cannabis its quintessentially “skunky” smell, (2) The Fruit Factor™ – the components that contribute to sweet or fruity flavors, (3) Strain Balance™ — the dispersal of terpenes in a flower, (4) Sensory Panel — describes the flavor and intended effects, and (5) the specific terpene and aroma compounds found within each cannabis strain ranked by concentration. We’ve mastered each of these and continue to create new advancements in our testing program so that we can assure unwavering consistency and standards for the most accurate recreation of any strain on the market,” says Koby.

For ABSTRAX, the release of its HTE catalog has placed the company in the position of standard-bearer for the production of cannabis terpene profiles for the State of California and beyond. “As legalization expands throughout the country and world, we expect our catalog will set the standard for the industry at large,” says Koby.

About ABSTRAX

Leveraging its proven background in cannabis research, ABSTRAX is the leader in the research, development, and production of botanically-derived and cannabis-inspired terpenes that create unforgettable sensorial experiences. Headquartered in California, the company owns and operates a state-of-the-art type 7 licensed research and manufacturing lab where it’s award-winning product developers and scientists leverage the most advanced strain analysis technology to extract and study aroma compounds via three-dimensional analysis, allowing for each and every compound within a plant to be named and studied. The company has partnered with many of the best cultivators in the industry to study their cannabis profiles and create the world’s most advanced terpene formulations. As a result of its efforts, ABSTRAX offers the largest terpene catalogue of the most popular strains – botanically-derived terpene blends and isolates native to cannabis. These ingredients, also known as functional flavors and aromas, are used in vapes, concentrates, edibles, beer, essential oils, fragrances, cosmetics, topicals, tinctures, alcohol, food and beverage, personal care, and more. The company works with internationally recognized brands and provides unparalleled cannabis research, innovation, and custom formulations to create products that engage and thrill consumers. ABSTRAX also devotes significant resources to developing the highest terpene standards and best practices in the industry. The company has developed a robust quality management system including Gas Chromatography analysis and molecular distillation of natural ingredients to achieve the highest purity standards. Investigating and ensuring that ingredients used in its own products, and products within its industry, are safe for consumption. The terpene industry is a rapidly growing segment of the global flavor and fragrance market, which is expected to grow to $35 billion by 2024. This market segment includes the cannabis, CBD, skincare, cosmetics, health and wellness, food and beverage industries. For more information, visit AbstraxTech.com.

Successful In-Facility Product Testing with CCam™ focus 360º Recording and Streaming Solution


Successful In-Facility Product Testing using CCam focus

CCam™ focus is glad to be part of IIEX Health’s advocacy for innovating healthcare research methods and providing a platform for insights leaders to achieve better business impact.

CCam™ focus, powered by Civicom Marketing Research Services, was a Gold Sponsor and Speaker for the recently held IIEX Health, one in a series of this year’s virtual GreenBook events, held on November 5th, 2020.

IIEX is a leading global event series that offers programs that discuss valuable insights trends in the healthcare industry. Part of GreenBook’s advocacy to bridge the gap between marketers and consumer insight, it provides a platform for thought leaders to share ideas and methods that can help insights professionals innovate their research and keep them ahead of the game.

This year’s event was held virtually to adhere to the protocols of the pandemic while offering the same collaborative and enlightening benefits of attending in-person. Participants received cutting edge ideas from major healthcare and pharmaceutical companies as well as leading research strategists in the community.

In support of the event, CCam™ focus joined alongside experts as a gold sponsor and speaker. CCam™ focus delivered a case study with New Perspectives Research, entitled “Five Steps to Successful In-Facility Product Testing Right Now,” that showcased the value of a unique hybrid approach (combination of in-person and online) for conducting product testing and how it can be accomplished efficiently using CCam™ focus technology while still following the requirements of the new norm.

Interested parties can view a recording of a presentation by clicking here.

About Civicom® CCam™ focus – HD 360° Focus Groups With Integrated Video Curation Tools

CCam™ focus is an HD 360º recording and streaming solution for in-person research, ideal for the new safety protocols. The omnidirectional camera with built-in microphones simultaneously captures a panoramic view as well as full-face video that adjusts when the speaker changes, fully capturing body language and sentiment. CCam™ focus delivers high definition visuals and superior audio even when the participants are wearing masks or are seated behind plexiglass. The result is omnidirectional viewing of all participants.

Integrated video curation tools assure video deliverables are generated within minutes for review of key moments. Civicom provides personalized service and support for set up, troubleshooting, and assistance throughout every session. CCam focus is also portable for plug and play situations, enabling market researchers to record and stream in-person interviews and focus groups from any location.

This quality focus group solution is part of Civicom Marketing Research Services group, the global industry leader in facilitating web-enabled in-depth interviews and focus groups through web-enabled technology.

For more information, email contact(at)ccamfocus.com or visit https://civicommrs.com/ccamfocus.

Share article on social media or email: